OTC and ornithine carbamoyltransferase deficiency: Additionally, in 1999, a patient with partial ornithine transcarbamylase (OTC) deficiency received a high intravenous dose, 3.8 × 1013 particles, of AV encoding the OTC gene, and this treatment proved to be fatal [970].